ArticlePDF Available

Citizen science to further precision medicine: From vision to implementation

Authors:

Abstract

The active involvement of citizen scientists in setting research agendas, partnering with academic investigators to conduct research, analyzing and disseminating results, and implementing learnings from research can improve both processes and outcomes. Adopting a citizen science approach to the practice of precision medicine in clinical care and research will require healthcare providers, researchers, and institutions to address a number of technical, organizational, and citizen scientist collaboration issues. Some changes can be made with relative ease, while others will necessitate cultural shifts, redistribution of power, recommitment to shared goals, and improved communication. This perspective, based on a workshop held at the 2018 AMIA Annual Symposium, identifies current barriers and needed changes to facilitate broad adoption of a citizen science-based approach in healthcare.
Perspective
Citizen science to further precision medicine: from vision
to implementation
Carolyn Petersen,
1
Robin R. Austin,
2
Uba Backonja,
3,4
Hugo Campos,
5
Arlene E.
Chung,
6
Eric B. Hekler,
7
Pei-Yun S. Hsueh,
8
Katherine K. Kim,
9
Anthony Pho,
10
Liz Salmi,
11
Anthony Solomonides,
12
and Rupa S. Valdez
13
1
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA,
2
School of Nursing, University of
Minnesota, Minneapolis, Minnesota, USA,
3
Nursing & Healthcare Leadership, University of Washington Tacoma, Tacoma, Wash-
ington, USA,
4
Biomedical Informatics & Medical Education, University of Washington School of Med icine, Seatt le, Wa shing-
ton, USA,
5
Kaiser Permanente, Kaiser Permanente Innovation, Oakland, California, USA,
6
Departments of Internal Medicine and
Pediatrics & the Program on Health & Clinical Informatics, UNC School of Medicine, Chapel Hill, North Carolina, USA,
7
Depart-
ment of Family Medicine & Public Health, Center for Wireless & Population Health Systems, Design Lab, Qualcomm Institute, Uni-
versity of California-San Diego, San Diego, California, USA,
8
Center for Computational Health, IBM TJ Watson Research Center,
Yorktown Heights, New York, USA,
9
Betty Irene Moore School of Nursing, Department of Public Health Sciences-School of Medi-
cine, University of California-Davis, Sacramento, California, USA,
10
School of Nursing, Columbia University, New York, New York,
USA,
11
OpenNotes/Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA,
12
Family Medicine, NorthShore Univer-
sity HealthSystem, Evanston, Illinois, USA and
13
Department of Public Health Sciences, University of Virginia School of Medicine,
Charlottesville, Virginia, USA
Corresponding Author: Carolyn Petersen, MS, MBI, FAMIA, Division of Biomedical Statistics and Informatics,
Mayo Clinic, Minnesota BioBusiness Building, Rochester, MN, 55905, USA; petersen.carolyn@mayo.edu
Received 15 January 2019; Revised 4 September 2019; Editorial Decision 7 October 2019; Accepted 25 October 2019
ABSTRACT
The active involvement of citizen scientists in setting research agendas, partnering with academic investigators
to conduct research, analyzing and disseminating results, and implementing learnings from research can im-
prove both processes and outcomes. Adopting a citizen science approach to the practice of precision medicine
in clinical care and research will require healthcare providers, researchers, and institutions to address a number
of technical, organizational, and citizen scientist collaboration issues. Some changes can be made with relative
ease, while others will necessitate cultural shifts, redistribution of power, recommitment to shared goals, and
improved communication. This perspective, based on a workshop held at the 2018 AMIA Annual Symposium,
identifies current barriers and needed changes to facilitate broad adoption of a citizen science-based approach
in healthcare.
Key words: research methodology, healthcare systems, community participation, consumer involvement, patient acceptance of
healthcare, citizen science
INTRODUCTION
Precision medicine has been defined as the development of preven-
tion and treatment strategies that take individual variability into ac-
count.
1
To date, precision medicine research efforts (eg, All of Us
Research Program
2
) have emphasized largely expert-driven efforts
for better identifying different interventions that work for different
people at different times. A central promise of precision medicine is
prevention and treatment approaches that move beyond “on
V
CThe Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com 1
JAMIA Open, 0(0), 2019, 1–7
doi: 10.1093/jamiaopen/ooz060
Perspective
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
average” patient responses
3
to create more personalized, targeted
interventions.
46
As evidenced by the extended discussion about var-
ious “precision” efforts,
416
how to realize the vision of precision
medicine remains an open question. A key consideration is how to
include patients, citizens, patient innovators, patient informati-
cians, citizen scientists, and scientific citizens in the process and
how informatics infrastructure can incorporate these contributions
meaningfully.
Citizen science has been defined as “the general public engage-
ment in scientific research activities when citizens actively contribute
to science either with their intellectual effort or surrounding knowl-
edge or their tools and resources.”
17
Citizen science initiatives have
contributed to academic science and continue to broaden its scope
and depth.
18
Although much of the work is conducted outside the
walls of academia or other organizational settings via novel meth-
ods, some patients who take on the role of citizen scientists do use
traditional research and/or informatics approaches to answer their
questions.
19
Citizen science can empower individuals to generate scientific
questions and share their data. Citizens can generate answers to
population health questions of interest to both patients and the
healthcare system,
20,21
making citizen science a feasible approach to
healthcare research.
2225
Citizen science offers an opportunity to
empower marginalized groups, such as sexual and gender minori-
ties, to shape scientific inquiry through participation.
26,27
Engage-
ment of citizen scientists enables studies that aren’t accessible
without them. Technological advances, changing reimbursement
models, innovative informed consent approaches, and other factors
are driving a shift in power dynamics within healthcare, affording
greater integration of citizen scientists’ work into research and clini-
cal care.
2832
Citizen science has the potential to extend and enhance the prac-
tice of precision medicine if healthcare practitioners and citizen sci-
entists work together to develop scientifically sound
approaches.
33,34
For example, the Personal Genome Project UK uses
a citizen science approach in which participants have consented to
open access release of personal genome, methylome, and transcrip-
tome data and analyses thought to influence gene function.
35
However, the general movement toward citizen science is more
mature in fields other than medicine, and this situation creates an
opportunity for informaticians to think through what citizen sci-
ence means—and could mean—in the informatics context. Within
fields such as biology, conservation, ecology, and astronomy, pre-
viously unimaginable insights into topics such as migration pat-
terns, scope of biodiversity, and asteroid surveillance have been
realized through citizen science-based approaches.
36
In compari-
son, citizen science-based efforts within the field of population
health, clinical medicine, and consumer health are relatively na-
scent.
21,3740
This viewpoint delineates the minimum technical, or-
ganizational, and citizen engagement requirements needed to
facilitate meaningful integration of citizen science into existing
healthcare systems. The following implementation recommenda-
tions were identified during an expert workshop held at the 2018
AMIA Annual Symposium.
TECHNICAL ISSUES
To support a diverse, open, integrated citizen science ecosystem, sev-
eral technical issues must be addressed. Though some considerations
are specific to citizen science, others relate more broadly to the
healthcare environment’s increasingly person-centric approach.
41
Platforms that facilitate collaboration among patients
and researchers
To accelerate participation, it is critical to have easily accessible, us-
able technology platforms that facilitate idea generation, prioritiza-
tion of research questions, community-building between citizens
and researchers, and results dissemination. Research networks have
demonstrated effective approaches to this challenge although these
projects relied on one-off technical tools.
4244
Crowdfunding plat-
forms have emerged as examples of how individuals, scientists, and
advocates can reach out to the public for donations and invest-
ments.
45
Although participants have primarily used these platforms
for outreach purposes, these platforms have not enabled collabora-
tive generation of science. Hence, an open-source approach that
citizen-scientist communities could leverage and build upon could
accelerate patient and researcher matching.
A distributed network
Citizen science at scale requires a network facilitating movement of
heterogeneous data sources into a large-scale system in real time.
Such a centralized system, however, further necessitates creating a
governing body which is still able to preserve and promote citizen
scientists’ autonomy within such a framework. In addition, such a
network must facilitate compliance with local and national privacy
regulations, among others. The growth in infrastructure that facili-
tates data sharing will support greater implementation of citizen sci-
ence,
46
so resolution of governance and related infrastructure issues
is paramount. Platforms designed specifically for citizen science
projects support this objective.
47
Advancing ethical structures to
achieve safety, as used in some patient-led efforts such as the Con-
nected and Open Research Exchange,
48
is critical.
49,50
Functionality for tracing provenance of data
contributions from individual data sources
The ability to potentially track the provenance of common types of
data from individuals and organizations is recommended so investi-
gators can explain underlying assumptions and potential sources of
bias in studies. These metadata should be collected only when indi-
viduals wish to have identifiable data elements shared. Ideally, such
functionality would support the remuneration of individuals in ex-
change for sharing their data. Of course, when participants desire to
make personal data open access, as in PGP-UK,
35
system functional-
ity should support this approach as well, provided that the shared
personal data fall under regulation.
Functionality supporting citizen scientist access to their
own health information
Tools that give citizen scientists access to their complete health in-
formation (eg, clinical notes, lab results, and radiology reports) are
central to advancement of the field. This requirement is important
because people who read medical notes report having a better under-
standing of their conditions, are more likely to take medications as
prescribed, and report greater satisfaction and trust of their doc-
tors.
51,52
Similarly, access to diverse types of data from electronic
health records will allow people to provision access and sharing of
their personal data. It is important to acknowledge that individuals
may have a range of motivations that lead to their participation as
citizen scientists. It will be essential for those engaged in supporting
and promoting citizen science efforts in precision medicine to under-
stand and be responsive to this range of motivations, which may
span from an interest in improving individual health to contributing
2JAMIA Open, 2019, Vol. 0, No. 0
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
to a larger social movement. Technology that provides citizen scien-
tists some control over the management and sharing of data they
contributed will also incentivize research engagement.
53
A standardized, comprehensive approach to
identification and resolution of barriers to data access
Citizen scientists need a standardized process for identifying and
addressing local, state, and federal policies that hinder or obstruct
access to personal health data. This article was formulated in the
context of the US-based healthcare system. Within this context,
patients are increasingly expected to assume responsibilities related
to managing their own health. Proactive management of personal
health benefits from access to data from health providers is currently
difficult to obtain due to restrictive policies. Although we expect cit-
izen scientists to play a key role in advocating for revised policies, it
will be essential to create structures for sharing the burden of
change, particularly in under-resourced settings. With such a process
in place, they could then identify ways to facilitate patients’ access
to their health data. For example, they could negotiate an under-
standing among competing health systems to adopt a data access
policy providing equivalent access for all patients, thereby reducing
the impact of differences in how health systems manage and share
data. Such understandings will be critical in the future as greater
quantities of genomic data become available and both traditional
researchers and citizen scientists seek to use multiple datasets to an-
swer questions of interest.
ORGANIZATIONAL ISSUES
Traditional research institutions must address a number of organiza-
tional issues to work effectively with citizen scientists.
Need to honor agency in individuals, families, and
communities
For citizen science work to thrive, organizations should avoid treat-
ing engaged patients as the exception or as token participants in a
provider-centric system. Acknowledging the contributions of the in-
dividual, family, and community implies respect and an understand-
ing that everyone comes to the table with different abilities and
perspectives. The ideal of honoring agency strives to reduce the au-
thoritative assumption that individuals, families, or communities
need to become “engaged,” when in reality they already are, though
perhaps outside the priorities of healthcare institutions. It includes
recognition of the many forms of expertise that each person (includ-
ing patients) possesses that facilitate progress toward healthier liv-
ing, the need to honor the validity of different perspectives,
54
and
the need to build empathy and acknowledgement of power differen-
tials as a potentially hidden barrier to equitable participation, con-
tribution, and benefit.
55
Commitment to ethical behavior
Organizations must develop an ethical framework rooted in com-
munity values on which to base citizen science efforts.
56
This
framework should inform a broad spectrum of issues, including
but not limited to privacy, security, data ownership, informed con-
sent, consideration of potential unintended consequences of data
sharing, and patient and researcher access. Such a framework
would inform how a local citizen science community might create
a collaborative, less hierarchical culture based on mutual respect
(rather than power) and ethical behavior by all that rewards curi-
osity and fosters trustworthiness. Substantive work has already
been undertaken in this area, as evidenced by the European Citizen
Science Association’s “Ten Principles of Citizen Science,” which
(among other things) emphasize mutual benefit to professional and
citizen scientists, availability of project data and metadata to the
public, and acknowledgement of citizen scientists in results and
publications.
57
Research questions that arise from citizen scientists,
rather than researchers, in a community-based participatory re-
search environment, offer another way to honor the commitment
to ethical behavior.
New and expanded funding models
Because citizen science is participant-driven, it often lacks access to
the traditional sources of funding (eg, government research awards,
foundation grants) that support research in universities and aca-
demic medical centers. Within the United States, funding institutions
(eg, the Robert Wood Johnson Foundation, the National Institutes
of Health) have demonstrated growing interests in models of citizen
science and those that are closely related, such as community-based
participatory research. These funding opportunities, however, fol-
low conventional models of time constraints. As such, while there
are growing opportunities to initiate citizen-science-based research
efforts, questions of sustainability remain unanswered. Funding
structures for citizen science, including financial models that explore
contribution of data where participants have substantial involve-
ment, are needed. Patient-powered research networks may be such a
model, although their sustainability too remains unproven.
New research models
Partnering institutions must embrace a variety of research models.
Health- and self-related citizen science does not necessarily imply a
shared experience, but technology can support both scientific
endeavors and varied forms of sharing and network-building. Many
technology adaptations have been developed as part of the Quanti-
fied Self movement (eg, information retrieval skills for evidence
gathering, measurement device development, provider alliances
based on shared decision-making),
58
and these and other approaches
need to be developed and implemented more broadly.
59
The use of
self-monitoring technologies to create persuasive performance feed-
back that motivates technology users to continue practicing healthy
behaviors for further health improvement is one such new model.
60
Crowdfunding and crowdsourcing approaches have proven success-
ful in microbiome and metagenomics research,
61
and may offer op-
portunities for researcher-citizen scientist partnerships. Actively
engaging patients and caregivers to prevent medical errors has
resulted in new technology designs and improved communication
between clinicians and hospitalized patients.
62,63
Advancing an
“agile scientific” model
64
that focuses first on helping individuals
rather than on producing generalizable knowledge aligns with orga-
nizational structures such as learning healthcare systems, but with
clearer integration of citizen scientists.
65
Authoritative research and engagement guidelines
Patient-researcher partnerships in citizen science range from easily
identifiable relationship models (eg, mentorships, co-mentorships,
and patients as co-investigators) to nontraditional/creative solutions
(eg, patients as principal investigator, patients working indepen-
dently). Citizen science efforts follow a continuum from researcher-
initiated to citizen scientist-initiated, with truly collaborative models
residing in the middle of this spectrum. Each participation model
JAMIA Open, 2019, Vol. 0, No. 0 3
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
leads to different requirements, roles, and expectations for the indi-
viduals involved in the effort. All parties must seek to understand
how these new models fit within existing academic hierarchies and
promote successful collaboration. The growing community of
researchers with academic affiliations and research-minded patients
and patients doing citizen science requires mutually accepted guide-
lines for engagement and practice.
Broad outreach to allied groups for shared learning and
advancement
The current practice of citizen science, whether consciously de-
scribed as “citizen science,” as patient-clinician engagement,
66
or
otherwise, has evolved in many areas without reference to each
other. Although groups and programs have shared goals, needs, and
challenges, they often lack awareness of and access to each other,
and so miss opportunities for shared learning and development. Citi-
zen scientists who receive healthcare in the United States have a very
different experience than their counterparts in other regions where
universal healthcare, minimal copayment requirements, and rela-
tively smaller health disparities are the norm, and as such, their
practice of citizen science naturally has evolved differently. US-
based citizen scientists in healthcare may learn from colleagues prac-
ticing citizen science elsewhere, wholesale adoption of and align-
ment with other national models is neither likely nor necessarily
beneficial. Citizen science practiced in the United States, in particu-
lar, needs infrastructure that facilitates communication and informa-
tion sharing among organizations, programs, citizen scientists
working in other regions, and potential partners (e.g., funders, gov-
ernment agencies).
COLLABORATION ISSUES
In addition to technical and organizational issues, several collabora-
tion barriers must be broken down.
Failure to see patients as collaborators
Many healthcare institutions lack a culture of working with citizen
scientists and may require deconstruction of a top-down culture that
locates authority in medical professionals. A foundation for culture
change arises through recognition of the value of patient-clinician
partnerships;
67
healthcare organizations must consciously work to-
ward this goal. The historical failure to recognize citizen scientists as
qualified interpreters of human genomes and related material must
be addressed going forward.
68
Targeted approaches for bringing patients into research
efforts
Because patients may have little background in science, they may
need training in research methodology, ethics, and regulation.
Training has already been proven feasible and productive.
69,70
When participants can contribute and prioritize research questions,
and then see the progression from idea to research study to results,
their interest and participation are reinforced.
71
Planning research
efforts of limited duration may facilitate recruitment of patient-
researchers in that minimally ambitious efforts require less time of
patients who may already be juggling health needs, job and family
responsibilities, and other commitments.
72
Similarly, to ensure a
truly reciprocal effort, researchers and clinicians should undertake
training to develop skills in engaging and collaborating with
patients. Movement toward an effective model of citizen science will
require adopting principles of mutual respect and learning, in which
both patients and researchers are trained in ways to engage con-
structively with one another. In addition to efforts initiated by
researchers to engage citizen scientists, it will be essential to create
mechanisms that facilitate citizen scientist’s ability to find and reach
out to research partners.
Improved ability to find and include patient partners
Even when researchers wish to co-manage citizen science projects,
they may experience difficulty finding individuals with the necessary
background, interest, and time. Employing a participatory design
process led by a citizen governance council and the research team
has proven successful for generating participation and engagement
guidelines and for ways to encourage participation throughout the
entire research lifecycle in a patient-powered research network.
69
For example, Citizen Endo project participants self-track endometri-
osis symptoms, an activity that researchers are studying as a way to
phenotype the condition,
73,74
and the “Make the Breast Pump Not
Suck” project recruited nursing mothers to help redesign breast
pumps.
75,76
Other approaches that operate outside traditional foun-
dation and academic structures also are needed, in particular be-
cause although citizen scientists may actively seek clinical partners,
they typically experience difficulty finding them.
Openness to meeting citizen scientists at varying skill
levels
Not all participants come to citizen science with the same set of
skills or background. Each situation presents a unique set of chal-
lenges that motivate individuals to explore new solutions. Academ-
ics learn their trades through a prescribed curriculum, but citizen
scientists in healthcare learn out of the need to survive or improve
quality of life, sheer curiosity, or a combination of the two. Health-
care organizations and researchers need to build capacity for engag-
ing citizen scientists with variable skill sets and to help them to grow
into increasing responsibility within teams as the partnership
matures. Large-scale efforts that engage citizen scientists with mini-
mal formal training, such as the American Gut Project, in which
self-selected citizen scientists mailed samples through the mail at
room temperature, have proven feasible and efficacious.
77,78
Trust-building as an essential target and skillset
Although citizen scientists in health are keen to contribute meaning-
fully to research, they often have had negative and/or unhelpful
experiences in healthcare and research environments, which may be
particularly acute among marginalized populations.
7987
These
experiences may have left them mistrustful of providers, researchers,
and others working within health systems and academia. Citizen sci-
ence will be advanced more quickly and effectively when those in
healthcare focus on gauging readiness to participate at various
points of the research pipeline and establishing trust with and
among patients doing citizen science.
88,89
Progress will advance
more quickly when researchers use tools and strategies designed to
build trust, such as more comprehensive approaches to informed
consent that both inform and engage citizen scientists.
35,90
CONCLUSION
Collaboration of citizen scientists and professional scientists sup-
ports the goals of knowledge generation and support for action.
Citizens not only assist scientists, but also work across the spectrum
4JAMIA Open, 2019, Vol. 0, No. 0
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
of informatics: data (fact/observation collection), information (data
analysis), knowledge (information refinement), and wisdom (knowl-
edge generation for the greater good). Such collaboration in preci-
sion medicine is necessary to fully capture the meaningful
differences that indicate which intervention to use, for whom, and in
what context. Healthcare organizations can, and should, integrate
citizen scientists into infrastructures that support evidence genera-
tion both for and with citizens. Citizen science has extraordinary po-
tential to extend and enhance the practice of precision medicine if
certain technical, organizational, and citizen engagement issues are
addressed appropriately.
FUNDING
The authors have no funding sources to declare.
AUTHOR CONTRIBUTIONS
CP, RA, UB, HC, AEC, EBH, P-YSH, KKK, AP, LS, AS, and RSV
developed the ideas in this manuscript, wrote and edited the text,
and revised the manuscript.
ETHICS STATEMENT
No humans or human materials were used in the production of this
work, and no Institutional Review Board approvals were required.
ACKNOWLEDGMENT
The authors gratefully acknowledge Dr. Jennifer Couch for her presentation
during the workshop. The authors would like to acknowledge and thank Dr.
Don E. Detmer for championing the importance of citizen science within AMIA
and for convening many of us interested in this novel area of informatics.
CONFLICT OF INTEREST
The authors have no competing interests.
REFERENCES
1. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J
Med 2015; 372 (9): 793–5.
2. National Institutes of Health. About the All of us Research Program.
Washington, DC: National Institutes of Health; 2017.
3. Fradkin JE, Hanlon MC, Rodgers GP. NIH precision medicine initiative:
implications for diabetes research. Dia Care 2016; 39 (7): 1080–4.
4. Arnett DK, Claas SA. Precision medicine, genomics, and public health.
Dia Care 2016; 39 (11): 1870–3.
5. Vaithinathan AG, Asokan V. Public health and precision medicine share a
goal. J Evid Based Med 2017; 10 (2): 76–80.
6. Yanovski SZ, Yanovski JA. Toward precision approaches for the preven-
tion and treatment of obesity. JAMA 2018; 319 (3): 223–4.
7. Akdis CA, Ballas ZK. Precision medicine and precision health: building
blocks to foster a revolutionary health care model. J Allergy Clin Immunol
2016; 137 (5): 1359–61.
8. Chambers DA, Feero WG, Khoury MJ. Convergence of implementation
science, precision medicine, and the learning health care system: a new
model for biomedical research. JAMA 2016; 315 (18): 1941–2.
9. Dolley S. Big data’s role in precision public health. Front Public Health
2018; 6: 68.
10. Dorsey SG, Resnick BM, Renn CL. Precision health: use of omics to opti-
mize self-management of chronic pain in aging. Res Gerontol Nurs 2018;
11 (1): 7–13.
11. Gambhir SS, Ge TJ, Vermesh O, et al. Toward achieving precision health.
Sci Transl Med 2018; 10 (430). pii: eaao3612.
12. Gillman MW, Hammond RA. Precision treatment and precision preven-
tion: integrating below and above the skin. JAMA Pediatr 2016; 170 (1):
9–10.
13. Kellogg RA, Dunn J, Snyder MP. Personal omics for precision health. Circ
Res 2018; 122 (9): 1169–71.
14. Khoury MJ, Galea S. Will precision medicine improve population health?
JAMA 2016; 316 (13): 1357–8.
15. Khoury MJ, Iademarco MF, Riley WT. Precision public health for the era
of precision medicine. Am J Prev Med 2016; 50 (3): 398–401.
16. Riveroll A, Thompson K, Robertson K, et al. Precision health: a personal-
ized approach to active health management. Can Med Biol Eng Sci 2018;
41: 1–5.
17. European Commission. Green Paper on Citizen Science for Europe: To-
wards a Society of Empowered Citizens and Enhanced Research. Brussels,
Belgium: European Commission; 2014.
18. Dick DM. Rethinking the way we do research: the benefits of community-
engaged, citizen science approaches and nontraditional collaborators. Al-
cohol Clin Exp Res 2017; 41 (11): 1849–56.
[19] Petersen C. Patient informaticians: turning patient voice into patient ac-
tion. JAMIA Open 2018; 1 (2): 130–5.
20. Buyx A, Del Savio L, Prainsack B, et al. Every participant is a PI. Citizen
science and participatory governance in population studies. Int J Epide-
miol 2017; 46 (2): 377–84.
21. Den Broeder L, Devilee J, Van Oers H, et al. Citizen science for public
health. Health Promot Int 2018; 33 (3): 505–14.
22. Armstrong AW, Cheeney S, Wu J, et al. Harnessing the power of crowds.
Am J Clin Dermatol 2012; 13 (6): 405–6.
23. de Weger LA, Hiemstra PS, Op den Buysch E, et al. Spatiotemporal moni-
toring of allergic rhinitis symptoms in The Netherlands using citizen sci-
ence. Allergy 2014; 69 (8): 1085–91.
24. Follett R, Strezov V. An analysis of citizen science based research: usage
and publication patterns. PLoS One 2015; 10 (11): e0143687.
25. Ranard BL, Ha YP, Meisel ZF, et al. Crowdsourcing–harnessing the
masses to advance health and medicine, a systematic review. J Gen Intern
Med 2014; 29 (1): 187–203.
26. University of California San Francisco. The Pride Study. San Francisco,
CA: University of California San Francisco; 2015.
27. PCORnet PPRN Consortium, Daugherty SE, Wahba S, Fleurence R. Pa-
tient-powered research networks: building capacity for conducting
patient-centered clinical outcomes research. J Am Med Inform Assoc
2014; 21 (4): 583–6.
28. King AC, Winter SJ, Sheats JL, et al. Leveraging citizen science and infor-
mation technology for population physical activity promotion. Transl J
Am Coll Sports Med 2016; 1 (4): 30–4.
29. Garrison LP Jr, Towse A. Value-based pricing and reimbursement in per-
sonalised healthcare: introduction to the basic health economics. J Pers
Med 2017; 7 (3). pii: E10.
30. Welch BM, Marshall E, Qanungo S, et al. Teleconsent: a novel approach
to obtain informed consent for research. Contemp Clin Trials Commun
2016; 3: 74–9.
31. Kondylakis H, Koumakis L, H
anold S, et al. Donor’s support tool: en-
abling informed secondary use of patient’s biomaterial and personal data.
Int J Med Inform 2017; 97: 282–92.
32. Kaye J, Whitley EA, Lund D, et al. Dynamic consent: a patient interface
for twenty-first century research networks. Eur J Hum Genet 2015; 23
(2): 141–6.
33.
Ozdemir V, Badr KF, Dove ES, et al. Crowd-funded micro-grants for ge-
nomics and “big data”: an actionable idea connecting small (artisan) sci-
ence, infrastructure science, and citizen philanthropy. OMICS 2013; 17
(4): 161–72.
34. Haga SB, Rosanbalm KD, Boles L, et al. Promoting public awareness and
engagement in genome sciences. J Genet Counsel 2013; 22 (4): 508–16.
35. PGP-UK Consortium. Personal Genome Project UK (PGP-UK): a research
and citizen science hybrid project in support of personalized medicine.
BMC Med Genomics 2018; 11: 108.
JAMIA Open, 2019, Vol. 0, No. 0 5
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
36. National Aeronautics and Space Administration. Target Asteroids! Na-
tional Aeronautics and Space Administration. Washington, DC; 2019.
http://www.asteroidmission.org/get-involved/target-asteroids/ Accessed
May 11, 2019.
37. Bonney R, Phillips TB, Ballard HL, et al. Can citizen science enhance pub-
lic understanding of science? Public Underst Sci 2016; 25 (1): 2–16.
38. Bonney R, Shirk JL, Phillips TB, et al. Citizen science. Next steps for citi-
zen science. Science 2014; 343 (6178): 1436–7.
39. Riesch H, Potter C. Citizen science as seen by scientists: methodological,
epistemological and ethical dimensions. Public Underst Sci 2014; 23 (1):
107–20.
40. Sullivan BL, Aycrigg JL, Barry JH, et al. The eBird enterprise: an inte-
grated approach to development and application of citizen science. Biol
Conserv 2014; 169: 31–40.
41. American Medical Informatics Association. Redefining our Picture of
Health: Towards a Person-Centered Integrated Care, Research, Wellness,
and Community Ecosystem: A White Paper of the 2017 AMIA Policy Invi-
tational. Washington, DC: American Medical Informatics Association.
42. Khodyakov D, Grant S, Meeker D, et al. Comparative analysis of stake-
holder experiences with an online approach to prioritizing patient-
centered research topics. J Am Med Inform Assoc 2017; 24 (3): 537–43.
43. Kim KK, Khodyakov D, Marie K, et al. A novel stakeholder engagement
approach for patient-centered outcomes research. Med Care 2018; 56
(Suppl) (10 Suppl 1): S41–S47.
44. Sylvia LG, Hearing CM, Montana RE, et al. MoodNetwork: an innova-
tive approach to patient-centered research. Med Care 2018; 56 (Suppl)
(10 Suppl 1): S48–S52.
45. Bassani G, Marinelli N, Vismara S. Crowdfunding in healthcare. J Tech-
nol Transf 2019; 44 (4): 1290–310.
46. Stanford Medicine. Stanford Medicine 2018 Health Trends Report: The
Democratization of Health Care. https://med.stanford.edu/content/dam/
sm/school/documents/Health-Trends-Report/HTR-Designed-Version-12.
12.18-930am-PT.pdf Accessed December 13, 2018.
47. Wang Y, Kaplan N, Newman G, et al. CitSci.org: a new model for manag-
ing, documenting, and sharing citizen science data. PLoS Biol 2015; 13
(10): e1002280.
48. Nebeker C, Bloss C, Weibel N. 371. Connected and open research ethics
(CORE) initiative: engaging stakeholders to shape ethics in the digital age.
Biol Psychiatry 2017; 81(10) (Suppl): S151–S152.
49. Aungst H, Fishman JR, McGowan ML. Participatory genomic research:
ethical issues from the bottom up to the top down. Annu Rev Genom
Hum Genet 2017; 18 (1): 357–67.
50. Hekler E. Is it Safe? Opening Pathways. San Diego, CA. http://opening-
pathways.org/is-it-safe Accessed December 31, 2018.
51. Delbanco T, Walker J, Bell SK, et al. Inviting patients to read their doc-
tors’ notes: a quasi-experimental study and a look ahead. Ann Intern Med
2012; 157 (7): 461–70.
52. Bell SK, Gerard M, Fossa A, et al. A patient feedback reporting tool for
OpenNotes: implications for patient-clinician safety and quality partner-
ships. BMJ Qual Saf 2017; 26 (4): 312–22.
53. Petersen C. The future of patient engagement in the governance of shared
data. EGEMS 2016; 4 (2): 1214.
54. Lewis D. Spectrums of Perspective. San Diego, CA: Opening Pathways.
http://openingpathways.org/spectrums-of-perspective.
55. Sullivan M, Kone A, Senturia KD, et al. Researcher and researched—
community perspectives: toward bridging the gap. Health Educ Behav
2001; 28 (2): 130–49.
56. Khodyakov D, Mikesell L, Schraiber R, et al. On using ethical principles
of community-engaged research in translational science. Transl Res 2016;
171: 52–62.
57. European Citizen Science Association. Ten Principles of Citizen Science.
Berlin, Germany: European Citizen Science Association; 2018.
58. Almalki M, Gray K, Martin-Sanchez FJ. Refining the concepts of self-
quantification needed for health self-management: a thematic literature re-
view. Methods Inf Med 2017; 56 (1): 46–54.
59. Hinckson E, Schneider M, Winter SJ, et al. Citizen science applied to
building healthier community environments: advancing the field through
shared construct and measurement development. Int J Behav Nutr Phys
Act 2017; 14 (1): 133.
60. Choe EK, Lee B, Munson S, et al. Persuasive performance feedback: the ef-
fect of framing on self-efficacy. AMIA Annu Symp Proc 2013; 2013:
825–33.
61. Afshinnekoo E, Ahsanuddin S, Mason CA. Globalizing and crowdsourc-
ing biomedical research. Br Med Bull 2016; 120 (1): 27–33.
62. Haldar S, Mishra SR, Khelifi M, et al. Opportunities and design considera-
tions for peer support in a hospital setting. Proc SIGCHI Conf Hum Fac-
tor Comput Syst 2017; 2017: 867–79.
63. University of Washington Information School. Patients as Safeguards. Se-
attle, WA: University of Washington Information School. https://patient-
sassafeguards.ischool.uw.edu/ Accessed May 11, 2019.
64. Agile Science. What is Agile Science? Tempe, AZ: Agile Science; 2015.
65. Hekler EB, Klasnja P, Riley WT, et al. Agile science: creating useful prod-
ucts for behavior change in the real world. Behav Med Pract Policy Res
2016; 6 (2): 317–28.
66. Patient-Centered Research Outcomes Institute. NAPCRG’s Patient and
Clinician Engagement (PaCE) Program 2.0.; 2016. https://www.pcori.
org/research-results/2016/napcrgs-patient-and-clinician-engagement-
pace-program-20 Accessed December 13, 2018.
67. Nickel WK, Weinberger SE, Guze PA; for the Patient Partnership in
Healthcare Committee of the American College of Physicians. Principles
for patient and family partnership in care: an American College of Physi-
cians position paper. Ann Intern Med 2018; 169 (11): 796–9.
68. Reardon J. The ‘persons’ and ‘genomics’ of personal genomics. Per Med
2011; 8 (1): 95–107.
69. Chung AE, Sandler RS, Long MD, et al. Harnessing person-generated
health data to accelerate patient-centered outcomes research: the Crohn’s
and Colitis Foundation of America PCORnet patient powered research
network (CCFA Partners). J Am Med Inform Assoc 2016; 23 (3): 485–90.
70. Chung AE, Vu MB, Myers K, et al. Crohn’s and Colitis Foundation of
America partners patient-powered research network: patient perspectives
on facilitators and barriers to building an impactful patient-powered re-
search network. Med Care 2018; 56 (Suppl 10) (Suppl 1): S33–S40.
71. Kim KK, Helfand M. Engagement in PCORnet research networks. Med
Care 2018; 56 (Suppl 10) (Suppl 1): S1–S3.
72. Leese J, Macdonald G, Kerr S, et al. Adding another spinning plate to an
already busy life’. Benefits and risks in patient-partner-researcher relation-
ships: a qualitative study of patient partners’ experiences in a Canadian
health research setting. BMJ Open 2018; 8 (8): e022154.
73. McKillop M, Voigt N, Schnall R, et al. Exploring self-tracking as a
participatory research activity among women with endometriosis. J
Participatory Med 2016; 8:e17. https://participatorymedicine.org/jour-
nal/evidence/research/2016/12/29/exploring-self-tracking-as-a-participa-
tory-research-activity-among-women-with-endometriosis/ Accessed
April 18, 2019.
74. McKillop M, Mamykina L, Elhadad N. Designing in the dark: eliciting
self-tracking dimensions for understanding enigmatic disease. In: Pro-
ceedings of the 36th Annual Association for Computing Machinery
Conference on Human Factors in Computing Systems; 2018. http://
people.dbmi.columbia.edu/noemie/papers/18chi.pdf Accessed April 18,
2019.
75. Make the Breast Pump Not Suck. Make the Breast Pump Not Suck Hacka-
thon. Cambridge, MA: Make the Breast Pump Not Suck; 2018.
76. Hope A, D’Ignazio C, Hoy J, et al. Hackathons as participatory design: it-
erating feminist utopias. In: CHI Conference on Human Factors in Com-
puting Systems Proceedings (CHI 2019); May 4–9, 2019; Glasgow,
Scotland, UK. ACM, New York, NY. 2019. https://dl.acm.org/citation.
cfm? id¼3300291 Accessed May 11, 2019.
77. McDonald D, Hornig M, Lozupone C, et al. Towards large-cohort com-
parative studies to define the factors influencing the gut microbial com-
munity structure of ASD patients. Microb Ecol Health Dis 2015; 26:
26555.
78. McDonald D, Hyde E, Debelius JW, et al. American Gut: an open plat-
form for citizen science microbiome research. mSystems 2018; 3 (3). pii:
e00031–18.
6JAMIA Open, 2019, Vol. 0, No. 0
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
79. Whitehead J, Shaver J, Stephenson R. Outness, stigma, and primary health
care utilization among rural LGBT populations. PLoS One 2016; 11 (1):
e0146139.
80. LaVaccare S, Diamant AL, Friedman J, et al. Healthcare experiences of
underrepresented lesbian and bisexual women: a focus group qualitative
study. Health Equity 2018; 2 (1): 131–8.
81. Phelan SM, Burgess DJ, Yeazel MW, et al. Impact of weight bias and
stigma on quality of care and outcomes for patients with obesity. Obes
Rev 2015; 16 (4): 319–26.
82. Crenshaw K. Demarginalizing the intersection of race and sex: a black
feminist critique of antidiscrimination doctrine, feminist theory and anti-
racist politics. U Chi Legal F 1989; 1989: Article 8.
83. L
opez N, Gadsden VL. Health inequities, social determinants, and inter-
sectionality. In National Academy of Sciences Discussion Paper Perspec-
tives: Expert Voices in Health and Health Care, Washington, DC, USA;
2016: 1–15.
84. Bauer GR. Incorporating intersectionality theory into population health
research methodology: challenges and the potential to advance health eq-
uity. Soc Sci Med 2014; 110: 10–7.
85. McCann E, Lee R, Brown M. The experiences and support needs of people
with intellectual disabilities who identify as LGBT: a review of the litera-
ture. Res Dev Disabil 2016; 57: 39–53.
86. Ramasamy V, Rillotta F, Alexander J. Experiences of adults with in-
tellectual disability who identify as lesbian, gay, bisexual, transgen-
der, queer or questioning, intersex or asexual: a systematic review
protocol. JBI Database System Rev Implement Rep 2017; 15 (9):
2234–41.
87. Mattocks KM, Sullivan JC, Bertrand C, et al. Perceived stigma, discrimi-
nation, and disclosure of sexual orientation among a sample of lesbian vet-
erans receiving care in the Department of Veterans Affairs. LGBT Health
2015; 2 (2): 147–53.
88. Khodyakov D, Mikesell L, Bromley E. Trust and the ethical conduct of
community-engaged research. Eur J Pers Cent Healthc 2017; 5 (4): 522–6.
89. Wilkins CH. Effective engagement requires trust and being trustworthy.
Med Care 2018; 56 (Suppl 1): S6–S8.
90. Angrist M. Eyes wide open: the personal genome project, citizen science
and veracity in informed consent. Per Med 2009; 6 (6): 691–9.
JAMIA Open, 2019, Vol. 0, No. 0 7
Downloaded from https://academic.oup.com/jamiaopen/advance-article-abstract/doi/10.1093/jamiaopen/ooz060/5651081 by guest on 15 January 2020
... The review identified strengths and limitations of 4 main frameworks commonly deployed in the design of digital interventions: (1) the IDEAS framework, aimed at supporting the development of digital interventions for health behavior change and based on the IDEAS phases [4]; (2) the ORBIT (Obesity-Related Behavioral Intervention Trials) model [29], aimed at guiding the design of evidence-based behavioral treatments to prevent and treat chronic diseases, based on the 4 phases of design, preliminary testing, efficacy, and effectiveness research; (3) the MOST (Multiphase Optimization Strategy) model [30,31], aimed at optimizing the development of behavioral, biobehavioral, and biomedical interventions; and (4) the DTx RWE framework [5], inspired by ORBIT and based on the 4 phases model of development (design, develop, test, and monitor). The review also included the citizen science approach [32] as a relevant method informing the cocreation of DH solutions with the participation of all stakeholders. Citizen science has been defined as the general public engagement in scientific research activities, when citizens actively contribute to science either with their intellectual effort or surrounding knowledge or their tools and resources [33]. ...
... The design phase for these DH solutions started from a series of participatory sessions with all stakeholder groups (health professionals, policy makers, and families) to achieve an in-depth knowledge of the prevention needs in the target areas and to specify the requirements and prototyping of the DH tools by providing equitable consideration of the different stakeholders' perspectives, as well as building empathy and acknowledgment of any power differential [32]. ...
Article
Full-text available
The first 1000 days of a child’s life, spanning from the time of conception until 2 years of age, are a key period of laying down the foundations of optimum health, growth, and development across the lifespan. Although the role of health prevention programs targeting families and children in the first 1000 days of life is well recognized, investments in this key period are scarce, and the provision of adequate health care services is insufficient. The aim of this viewpoint is to provide a holistic digital health framework cocreated with policy makers, health care professionals, and families to support more effective efforts and health care programs dedicated to the first 1000 days of life as the first line of prevention. The framework provides recommendations for leveraging on behavioral intervention technology and digital therapeutics solutions augmented by artificial intelligence to support the effective deployment of health prevention programs to families. The framework also encourages the adoption of a citizen science approach to co-design and evolve the digital health interventions with all relevant stakeholders in a real-world research perspective.
... In the design of patient-tailored treatment, patients are key participants in finding easy-to-implement solutions. Patient experiences have been proven to be a valuable tool for gaining insight into individual patient values and how the health-related quality of life of different demographics can be maximized [66], especially given the unequal effectiveness of treatments among patients and the beneficial effects of creating tailored treatment options to address specific needs [1]. ...
Article
Full-text available
Atrial fibrillation (AF) is the most common heart rhythm disorder in the Western world. Between the years 2010 and 2019, the global prevalence of AF rose from 33.5 million to 59 million, highlighting the importance of developing equitable treatments for patients. The disease is associated with symptoms such as palpitations, dizziness, fatigue, shortness of breath, and cognitive dysfunction. In addition, AF increases the risk of developing a stroke and heart failure. Despite new insights into risk factors that can lead to the development of AF, the success of current treatments is suboptimal. Numerous risk factors, such as hypertension, diabetes, and obesity, have been associated with the development and progression of AF. As these can be lifestyle-related risk factors, lifestyle modification may be a solution to reduce AF-related symptoms as well as episodes. Research results show that certain dietary changes can reduce AF and numerous risk factors for AF. Increasing attention is being given to Mediterranean and whole, plant-based eating patterns, which emphasize eating grains, legumes, vegetables, fruits, and nuts, while excluding most—or all—animal products. Hence, what are the beneficial aspects of a Mediterranean and plant-based diet which consists mainly of unprocessed foods? In the current review, we discuss the outcomes of diet-based treatments. Moreover, other diet-related treatments, brought up by patient initiatives, are highlighted. These patient-initiated studies include L-glutamine and electrolytes as options to manage AF. Also, we highlight the emerging importance of valuing patient needs and a quality-of-life-centered approach to medicine. As indicated by recent studies and patient experiences, citizen science can create inclusive solutions that lead to patient empowerment and a holistic approach for AF management.
... The scores are then summed up and translated into a final score. Scores are considered low between 0 and 6 points, low-medium (7)(8)(9)(10)(11)(12), medium (13)(14)(15)(16)(17)(18)(19), medium-high (20)(21)(22)(23)(24)(25)(26), and high (27)(28)(29)(30)(31)(32). This score shows the quality of the study. ...
Article
Full-text available
Background: Citizen science is a research approach wherein citizens actively participate alongside professionals in some or all stages of the research process. The bidirectional benefits it generates, especially in the field of health, including empowerment, new hypotheses, and results, and addressing issues truly important to society, justify the necessity to establish a common framework and address barriers to ensure a fruitful evolution of this new approach within nursing research. The aim was to analyze nursing projects with a citizen science focus that have been conducted. Methods: PRISMA guidelines were employed to conduct a systematic review. Searches were conducted on PubMed, CINHAL, LILACS, IBECS, and Cochrane. Following the identification and screening process, 13 studies were included. The quality of the articles was assessed using the Joanna Brigg Institute (JBI) critical appraisal checklist and the quality of citizen science research using the Citizen Science Appraisal Tool. Results: Citizen science studies in nursing were notably recent (2017–2023). Five research areas were identified, with environmental health being the most predominant. Multiple tools, both technological and traditional, were utilized, with the “Photovoice” and “Our Voice” methodologies being prominent. Citizen participation was limited to data collection and analysis in 7 out of the 13 studies, with most studies working with small samples. Findings regarding the application of this practice were positive, but no study exceeded 26 points on the CSAT scale to be considered high quality in citizen science. Conclusions: Citizen science can be a promising approach within the field of nursing. There is a need to increase individual participation to fully realize the potential bidirectional benefits. It is imperative to establish a common theoretical framework and continue working on the development of this methodology within nursing.
... However, the application of citizen science approaches in the domain of health is underexploited [7] and limited to public health [8,9] because of the ease of involving local communities in public health issues [10]. The interest is increasing in expanding the use of citizen science approaches in other areas of health [11] to reap its benefits, such as exploitation of citizens experiences with health problems, increasing awareness about health issues, and improving health literacy. In addition, some research funders, such as the European Union and the National Institute for Health and Care Research in the United Kingdom, especially call for patient and public involvement and engagement in research, including clinical and biomedical research, particularly in the domain of translational medicine research, where citizen science is still in its infancy [12]. ...
Article
Full-text available
Citizen science is a participatory science approach in which members of the public (citizens) collaborate with scientists and professional researchers and become involved in research and innovation activities, resulting in the co-creation of scientific knowledge and innovation. Citizen science has been widely applied in research, particularly in the social sciences, environmental sciences, information and communication technologies, and public health. However, the application of this approach in clinical sciences, particularly in translational medicine research, is still nascent. This exploratory study involved members of the public (citizen scientists) in a translational medicine experiment on non-alcoholic fatty liver disease that incorporated a lifestyle and weight-loss intervention. The aim of this paper is to report successful methods and approaches for the recruitment, retention, and training of citizen scientists. For the citizen scientists’ recruitment, online calls placed on the websites of our research project and biomedical research center and targeted emails were the most helpful. Of the 14 members of the public who expressed interest in our study, six were recruited as citizen scientists. Citizen scientists were mostly female (n = 5, 83%), white (n = 3, 50%), over 50 years of age (n = 4, 67%), educated to postgraduate level (n = 5, 83%), and either retired or not in employment (n = 5, 83%). The retention rate was 83% (n = 5), and the dropout rate was 17% (n = 1). We arranged instructor-led interactive online training sessions (an hour-long one-on-one sessions and two-hour group sessions). Research skills training covered ethics in research and qualitative and quantitative data analysis. Citizen scientists were given several incentives, such as reimbursement of travel and care costs, selection as citizen scientists of the month, publications of their blogs and perspective articles, and coauthorship and acknowledgement in papers and project deliverables. To conclude, members of the public (particularly middle-aged white women with postgraduate education) are interested in becoming citizen scientists in translational medicine research. Their retention rate is higher, and they can contribute to different research activities. However, they need training to develop their research skills and expertise. The training should be simple, comprehensive, and flexible to accommodate the schedules of individual citizen scientists. They deserve incentives as they work on a voluntary basis.
... Social media, networking platforms, and PHI devices such as wearables can advance ODH where existing healthcare systems and infrastructure are already in place and where community involvement in problem elicitation and solution development are priorities. Informatics professionals have already envisioned a role and implementation strategies for citizen science as a way to address health inequities within ODH [46]. ...
Article
Full-text available
Objective: To identify links between Participatory Health Informatics (PHI) and the One Digital Health framework (ODH) and to show how PHI could be used as a catalyst or contributor to ODH. Methods: We have analyzed the addressed topics within the ODH framework in previous IMIA Yearbook contributions from our working group during the last 10 years. We have matched main themes with the ODH's framework three perspectives (individual health and wellbeing, population and society, and ecosystem). Results: PHI catalysts ODH individual health and wellbeing perspective by providing a more comprehensive view on human health, attitudes, and relations between human health and animal health. Integration of specific behavior change techniques or gamification strategies in digital solutions are effective to change behaviors which address the P5 paradigm. PHI supports the population and society perspective through the engagement of the various stakeholders in healthcare. At the same time, PHI might increase a risk for health inequities due to technologies inaccessible to all equally and challenges associated with this. PHI is a catalyst for the ecosystem perspective by contributing data into the digital health data ecosystem allowing for analysis of interrelations between the various data which in turn might provide links among all components of the healthcare ecosystem. Conclusion: Our results suggest that PHI can and will involve topics relating to ODH. As the ODH concept crystalizes and becomes increasingly influential, its themes will permeate and become embedded in PHI even more. We look forward to these developments and co-evolution of the two frameworks.
Article
Full-text available
In this systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol, we analyse 211 articles to identify the commonly studied factors impacting both the scientific and social outcomes of knowledge co-production through citizen science (hereby as ‘scientific and social outcomes’). First, we notice that a similar extent of scholarly attention goes to both outcomes in the academic discourses, and both outcomes are often addressed together. Second, we identify and synthesize twenty-nine variables into three themes, citizens, project settings, and broader context, and we argue these three perspectives need to be jointly analysed to understand knowledge co-production in citizen science. Third, we draw preliminary evidence and call for further empirical evidence to study the conditions of both outcomes. Our conceptual framework informs future studies by identifying the commonly studied factors that can be associated with the social and scientific characterization of knowledge co-produced through citizen science and necessitate further empirical investigations.
Article
Full-text available
Patient portal use among patients with cancer has increased significantly in recent years. This state-of-the-art review seeks to address and analyse literature involving patient portal use by patients with cancer and their care partners. In this review, we queried articles from PubMed published between January 2018 and April 2024 that describe recent trends and the current presence of portals in cancer care for patients, proxy users and/or care partners. We searched for articles addressing three overarching themes: (1) trends and disparities in portal adoption and use among patients with cancer, (2) use of specific portal components and functions in cancer care and (3) associations between portal use and cancer-related outcomes. Our search identified 278 unique studies, of which 82 were relevant empiric studies that met inclusion criteria and were included in this review. These papers aligned with 12 subthemes, including disparities in patient portal access, growing use of telemedicine via patient portal and patient access to immediately available to electronic health information. Our findings indicate that patient portals play an increasingly important role in helping patients manage their cancer care, despite few disparities that contribute to inequitable use. However, despite consistent growth in use over recent years, there are many areas for improvement in how portals support patients with cancer and a demand for functionality to continually evolve with patient needs.
Article
Clinical trials are crucial in developing safe medical treatments and combating diseases. However, the ethical considerations surrounding research involving human subjects have been an ongoing topic of debate. Existing ethical policies aim to ensure the accuracy of research findings and protect the well-being of participants. Nevertheless, these policies have been rooted in Western scientific and medical systems, which historically exploited communities for the benefit of privileged individuals and capital accumulation, perpetuating domination and settler colonialism. While ethical policies alone cannot erase these harmful legacies, they have globally failed at holding researchers, companies, and institutions accountable for their impact on communities. This failure has led to exploitation and unintended harm in disenfranchised communities with under-resourced health systems and limited access to healthcare resources. To address these challenges, this literature review proposes integrating stricter regulations, transparent disclosure of trial results, and comprehensive post-trial care. Additionally, it advocates for including community partnerships in clinical trial ethics policies to prioritize community needs and promote accountability. By examining qualitative studies on the perspectives of patients, researchers, and clinicians involved in clinical trials, as well as the current state of clinical trial ethics policies, this paper suggests a partnership-based approach that can facilitate the development of new treatments while addressing historical legacies of exploitation and harm in disenfranchised communities worldwide.
Article
Digital therapeutics (DTx) are a promising way to provide safe, effective, accessible, sustainable, scalable, and equitable approaches to advance individual and population health. However, developing and deploying DTx is inherently complex in that DTx includes multiple interacting components, such as tools to support activities like medication adherence, health behavior goal-setting or self-monitoring, and algorithms that adapt the provision of these according to individual needs that may change over time. While myriad frameworks exist for different phases of DTx development, no single framework exists to guide evidence production for DTx across its full life cycle, from initial DTx development to long-term use. To fill this gap, we propose the DTx real-world evidence (RWE) framework as a pragmatic, iterative, milestone-driven approach for developing DTx. The DTx RWE framework is derived from the 4-phase development model used for behavioral interventions, but it includes key adaptations that are specific to the unique characteristics of DTx. To ensure the highest level of fidelity to the needs of users, the framework also incorporates real-world data (RWD) across the entire life cycle of DTx development and use. The DTx RWE framework is intended for any group interested in developing and deploying DTx in real-world contexts, including those in industry, health care, public health, and academia. Moreover, entities that fund research that supports the development of DTx and agencies that regulate DTx might find the DTx RWE framework useful as they endeavor to improve how DTxcan advance individual and population health.
Article
Full-text available
Background: Molecular analyses such as whole-genome sequencing have become routine and are expected to be transformational for future healthcare and lifestyle decisions. Population-wide implementation of such analyses is, however, not without challenges, and multiple studies are ongoing to identify what these are and explore how they can be addressed. Methods: Defined as a research project, the Personal Genome Project UK (PGP-UK) is part of the global PGP network and focuses on open data sharing and citizen science to advance and accelerate personalized genomics and medicine. Results: Here we report our findings on using an open consent recruitment protocol, active participant involvement, open access release of personal genome, methylome and transcriptome data and associated analyses, including 47 new variants predicted to affect gene function and innovative reports based on the analysis of genetic and epigenetic variants. For this pilot study, we recruited 10 participants willing to actively engage as citizen scientists with the project. In addition, we introduce Genome Donation as a novel mechanism for openly sharing previously restricted data and discuss the first three donations received. Lastly, we present GenoME, a free, open-source educational app suitable for the lay public to allow exploration of personal genomes. Conclusions: Our findings demonstrate that citizen science-based approaches like PGP-UK have an important role to play in the public awareness, acceptance and implementation of genomics and personalized medicine. Keywords: Personal genomics, Open consent, Open access, Genome donation, Genome reports, Genome app, Citizen science
Article
Full-text available
Objective To better understand, based on patient partners’ experiences, benefits and risks in patient partner–researcher relationships in a health research setting. Design Qualitative interviews with thematic analysis informed by a relational ethics lens. Setting A multidisciplinary health research centre in Vancouver, Canada. This study was codeveloped by patient partners and researchers at the centre. Participants 22 people living with arthritis, with experience as members of a patient advisory board at the research centre from 1 month to 10 years. Results We identified three main themes: (1) Being Heard: Participants had experienced uncomfortable emotions (eg, feelings of insecurity) in their relationships with researchers. The discomfort, however, was minimised by the demonstration of mutual respect in their interactions. Specifically, participants valued environments without a hierarchy between patient partners and researchers, where contributions of each party were considered equally important, and where patients’ voices were heard; (2) Cobuilding social relations: Participants valued building social relations with researchers beyond their expected interactions as partners in research and (3) Adding another spinning plate to an already busy life: Participants valued relationships with researchers who had cocreated environments that minimised the risks of physical and emotional impacts (eg, fatigue, stress, guilt) on them while juggling multiple obligations, priorities and their health. Conclusions Findings provide valuable insights to guide relationship building between patient partners and researchers. Informed by a relational ethics lens, these findings are a critical step in supporting an ethically sound practice of patient engagement in research that prioritises patients’ perspectives.
Article
Full-text available
Introduction/objectives: The engagement of patients and other stakeholders is a critical element in the design of patient-centered outcomes research studies. However, methodology for scalable engagement in research management particularly activities such as operationalization of principles and setting of priorities is not well-developed. The objective of this study is to describe a novel approach for scalable stakeholder engagement in research aligned with the Patient-Centered Outcomes Research Institute (PCORI) engagement principles, which was evaluated in a national clinical data research network. Materials and methods: Patient, patient advocate, clinician, and researcher stakeholders were recruited from clinical sites, as well as social media sites related to the 3 conditions of focus, heart failure, obesity, and Kawasaki disease. The engagement strategy was designed, implemented, and mapped to the PCORI engagement principles. Evaluation included internal assessment and quantitative measures of online engagement. Results: We operationalized the PCORI principles with 12 stakeholder engagement strategies and convened stakeholder advisory boards and online research prioritization panels to determine research priorities in a rigorous, deliberative process. A total of 46 advisors (20 patients) and 339 panelists (159 patients) actively participated. There were not significant differences between patients and clinicians in level of online engagement. Nonetheless, while patients reported a slightly greater challenge with following online discussion, they overall had a more favorable opinion about use of the online format. Discussion/conclusion: An efficient way to engage large numbers of representative stakeholders in research is a necessary first step to assure the public of trustworthy use of data networks for health research. This paper describes a comprehensive approach to engagement in patient-centered outcomes research management that informs ongoing development of rigorous methodologies in this area.
Article
Full-text available
Background: To build a patient-powered research network (PPRN) that prioritizes the needs of its members who have inflammatory bowel diseases (IBD), we sought to better understand patients' preferences for what are the essential features that will facilitate and sustain engagement. Methods: We conducted a two-phase qualitative study. Seven focus groups involving 62 participants with IBD were conducted (phase 1). Focus group results informed the phase 2 cognitive interviews, which included 13 phone interviews. Topics included experiences with IBD and research, PPRN engagement, patient-generated health data, and resources/tools to facilitate self-management. All focus groups and interviews were digitally recorded, transcribed verbatim, and analyzed in ATLAS.ti 7.5. Thematic categories were derived from the data, and codes were grouped into emergent themes and relationships. Results: Four major themes emerged through inductive coding: (1) the impact of knowing; (2) participation barriers and challenges; (3) engagement and collaboration; and (4) customizable patient portal features/functionalities. Participants were motivated to participate in the PPRN because the knowledge gained from research studies would benefit both society and the individual. Main concerns included credibility of online resources, pharmaceutical industry profiting from their data, data security, and participation expectations. Participants wanted a true and equal partnership in every phase of building a PPRN. Participants felt it was important to have access to personal health records and be able to track health status and symptoms. Conclusion: Partnering with participants throughout PPRN development was critical to understanding the needs and preferences of patients with IBDs and for shaping engagement strategies and the portal's design.
Article
Full-text available
Introduction: Research has often been viewed as a passive process by which participants enroll in studies developed by researchers. It is becoming clearer that to understand the nuances of mood episodes and how to prevent them, we need to conduct large clinical trials that have the power to investigate moderators and mediators, or catalysts and mechanisms of change. MoodNetwork, the first online, patient-centered research community for individuals with mood disorders, aims to change the way that traditional research has been conducted by involving patients, their caregivers, and advocates in the process of research. The aim of this report is to share lessons learned from developing MoodNetwork. Methods: Participants enroll by completing a demographic survey and consent form. Once enrolled, participants are encouraged to complete optional surveys about their mood disorders and areas of research priority. Stakeholder and advocacy partners developed the website, web-based surveys, and recruitment materials. Results: MoodNetwork has enrolled 4103 participants to date. Of this sample, 96.9% report experiencing depression and 79.7% endorse symptoms of mania or hypomania. Participants rated reducing stigma and alleviating symptoms as their 2 largest research priorities. Recruitment has been slower than expected. Recruiting a diverse sample has been challenging, and this impacts the Network's ability to conduct comparative effectiveness research studies. Discussion: We discuss lessons learned from recruiting individuals with mood disorders to MoodNetwork, an innovative approach to conducting clinical trials. We identify and review 5 strategies for increasing enrollment as well as future directions.
Article
Full-text available
Purpose: To understand the complex healthcare experiences of women identifying as lesbian or bisexual. who are also women of color, veterans, and/or 65 years of age and older. Methods: Inclusion criteria were age 25 or older, Los Angeles County resident, self-identification as a lesbian or bisexual woman, and as an African American, Latina, Asian-Pacific Islander, and/or a veteran. For the age 65 years and older group, participants were eligible regardless of their veteran status or race/ethnicity. Five focus groups were conducted (n=35) and the same questions were asked addressing their comfort interacting with healthcare providers, the provider knowing their sexual orientation, characteristics of a perfect provider, and barriers to care. Structured qualitative analyses were performed. Results: Participants identified concerns that providers often hold to heterosexual cultural norms. Participants varied on preferences for providers of the same race/ethnicity as themselves. Lesbians who are 65 years and older identified legal barriers as major concerns. All groups identified incorrect provider assumptions about sexual orientation and sexual practices as frequently compromising their care. Participants supported the idea of certification for providers skilled in lesbian, gay, bisexual, transgender, and queer (LGBTQ) health, but expressed skepticism that such programs would necessarily result in better care. Conclusion: Healthcare provider trainings need to address the specific concerns and experiences of underrepresented lesbian and bisexual women. Healthcare environments must be transformed to effectively address their needs. More research is needed on the separate healthcare experiences of specific marginalized populations related to their sexual orientation and/or gender identity.
Article
Full-text available
Engaging patients and community stakeholders as partners in research requires effective communication, inclusion in decision making, and mutually respectful relationships. Developing and maintaining trust among stakeholders and researchers is critical for successful engagement, especially in partnerships involving patients or community stakeholders in which there is often an imbalance of power. Although patients and community members are assuming new roles and greater responsibility in research partnerships, they often rely on researchers to help navigate unfamiliar research settings and share resources. To enhance trust and produce more meaningful stakeholder involvement will require strategies that balance power dynamics, facilitate colearning, and recognize importance of researchers being trustworthy.
Article
In this position paper, the American College of Physicians (ACP) examines the rationale for patient and family partnership in care and reviews outcomes associated with this concept, including greater adherence to care plans, improved satisfaction, and lower costs. The paper also explores and acknowledges challenges associated with implementing patient- and family-centered models of care. On the basis of a comprehensive literature review and a multistakeholder vetting process, the ACP's Patient Partnership in Healthcare Committee developed a set of principles that form the foundation for authentic patient and family partnership in care. The principles position patients in their rightful place at the center of care while acknowledging the importance of partnership between the care team and patient in improving health care and reducing harm. The principles state that patients and families should be treated with dignity and respect, be active partners in all aspects of their care, contribute to the development and improvement of health care systems, and be partners in the education of health care professionals. This paper also recommends ways to implement these principles in daily practice.